1-3 of 3
Martin McLaughlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CXCL12-targeted immunomodulatory gene therapy reduces radiation-induced fibrosis in healthy tissues.

James T. Paget, Joseph A. Ward, Andrew R. McKean, David C. Mansfield, Martin McLaughlin, Joan N. Kyula-Currie, Henry G. Smith, Victoria Roulstone, Chunhei Li, You Zhou, Thomas Hardiman, Anita Grigoriadis, Devin O'Brien Coon, Sheeba Irshad, Alan A. Melcher, Kevin J. Harrington, Aadil Khan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024)
https://doi.org/10.1158/1535-7163.MCT-23-0872
Published: 12 December 2024
View article titled, CXCL12-targeted immunomodulatory gene therapy reduces radiation-induced fibrosis in healthy tissues.
Open the PDF for CXCL12-targeted immunomodulatory gene therapy reduces radiation-induced fibrosis in healthy tissues. in another window
Includes: Supplementary data
Journal Articles

Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang A. Bhide, Kate L. Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (1): 25–34.
https://doi.org/10.1158/1535-7163.MCT-16-0239
Published: 05 January 2017
View article titled, Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei
Open the PDF for Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei in another window
Includes: Supplementary data
Journal Articles

CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy

Holly E. Barker, Radhika Patel, Martin McLaughlin, Ulrike Schick, Shane Zaidi, Christopher M. Nutting, Katie L. Newbold, Shreerang Bhide, Kevin J. Harrington
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (9): 2042–2054.
https://doi.org/10.1158/1535-7163.MCT-15-0998
Published: 01 September 2016
View article titled, CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy
Open the PDF for CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy in another window
Includes: Supplementary data